Olix Logo.jpg
OliX Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for Improved Intracellular Delivery Platform Technology for RNAi Therapeutics
May 24, 2021 08:00 ET | OliX Pharmaceuticals
SUWON, Republic of Korea, May 24, 2021 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced that the Company has received a notice of...
22157.jpg
Global Oligonucleotide Synthesis Markets Report 2021-2026 - Increasing Use of Synthesized Oligos in Therapeutic Applications with Growing Focus on Personalized Medicine
May 20, 2021 04:38 ET | Research and Markets
Dublin, May 20, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market by Product (Drug, Synthesized Oligos (Primer, Probe), Reagents), Type (Custom, Predesign), Application (Therapeutic...
Capture.PNG
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases
April 28, 2021 07:00 ET | Silence Therapeutics plc
Silence Therapeutics Achieves Another Research Milestone Payment from Mallinckrodt Collaboration for Complement-Mediated Diseases 28 April 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq:...
22157.jpg
Global RNAi Technologies, Markets & Companies Report 2020-2028: Gene Editing with for COVID-19 by RNA-Targeting CRISPR Systems & mRNA Vaccines for COVID-19
April 20, 2021 06:23 ET | Research and Markets
Dublin, April 20, 2021 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The markets for RNAi...
ARC logo.png
Respiratory Assist Devices Market Value Predicted To Reach US$ 30.3 Billion By 2027: Acumen Research And Consulting
April 08, 2021 11:52 ET | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Respiratory Assist Devices Market– Global Industry Analysis, Market Size,...
22157.jpg
Global Antisense & RNAi Therapeutics Market (2020 to 2030) - Opportunities and Strategies
April 07, 2021 05:23 ET | Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
22157.jpg
Global Antisense and RNAi Therapeutics Market Report 2021: Market to Reach $1.9 Billion by 2027 - Antisense RNA Segment is Projected to Account for $974.2 Million
March 30, 2021 07:38 ET | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Antisense and RNAi Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
Global Viral Vector & Plasmid DNA Manufacturing Market Report 2021 - Rising Use of Viral Vectors in Several Treatments Demands Developments in Plasmids and Vectors
February 17, 2021 05:48 ET | Research and Markets
Dublin, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Workflow, by Application, by End User - Global Forecast to 2025 -...
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate
February 10, 2021 17:45 ET | OliX Pharmaceuticals
Company to discuss study results and present corporate overview at SMi’s 12th Annual RNA Therapeutics Virtual Conference on February 11 SUWON, Republic of Korea, Feb. 10, 2021 (GLOBE NEWSWIRE) --...
22157.jpg
Global RNA Interference Drug Delivery Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
December 21, 2020 06:53 ET | Research and Markets
Dublin, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The "RNA Interference (RNAi) Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...